Leggett R W
Environmental Sciences Division, Building 5700, Room O101, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA.
J Radiol Prot. 2013 Mar;33(1):123-40. doi: 10.1088/0952-4746/33/1/123. Epub 2013 Jan 7.
The International Commission on Radiological Protection (ICRP) is preparing a series of reports that will provide updated biokinetic and dosimetric models and dose coefficients for occupational intake of radionuclides. The biokinetic modelling scheme continues a trend in ICRP reports towards physiologically realistic descriptions of the time-dependent behaviour of absorbed radionuclides and their radioactive progeny. This paper proposes systemic biokinetic models for caesium isotopes and their ingrowing chain members and examines the dosimetric implications of the proposed models. Comparisons of D68 = tissue dose per unit input to blood based on current ICRP models for workers (ICRP Publication 68, 1994) with DP = corresponding values based on the proposed biokinetic models (but using the dosimetry models of Publication 68) yields the following ranges of the ratios DP:D68 for the tissues addressed in Publication 68: 0.5-25 for (130)Cs (T1/2 = 29.2 min), 0.6-9.5 for (134m)Cs (2.9 h), 0.7-1.7 for (131)Cs (9.69 d), 0.7-1.1 for (134)Cs (2.06 y), 0.5-1.9 for (137)Cs (30.2 y) and 0.2-3.7 for (135)Cs (2.3 × 10(6) y). The large differences in the derived dose coefficients for some tissues and caesium isotopes, particularly short-lived isotopes, result mainly from differences in predictions of the time-dependent distributions of caesium in the body. For example, the proposed model and the current ICRP model for occupational intake of caesium predict peak kidney contents of ∼22% and ∼0.4%, respectively, following intravenous injection of stable caesium. Based on the proposed models for caesium and its progeny, the only dosimetrically significant chain members of caesium isotopes with half-life ≥10 min are (137m)Ba, which represents 32-85% of the estimated tissue doses from injected (137)Cs, and (134)Cs, which represents 4-53% of the estimated tissue doses from injected (134m)Cs.
国际放射防护委员会(ICRP)正在编写一系列报告,这些报告将提供关于放射性核素职业摄入量的更新的生物动力学和剂量学模型以及剂量系数。生物动力学建模方案延续了ICRP报告中对吸收的放射性核素及其放射性子体随时间变化行为进行生理现实描述的趋势。本文提出了铯同位素及其生长链成员的系统生物动力学模型,并研究了所提模型的剂量学意义。将基于当前ICRP针对工作人员的模型(ICRP第68号出版物,1994年)得出的D68 = 每单位血液输入的组织剂量与基于所提生物动力学模型(但使用第68号出版物的剂量学模型)得出的DP = 相应值进行比较,得出ICRP第68号出版物中所涉及组织的DP:D68比值范围如下:对于(130)Cs(T1/2 = 29.2分钟)为0.5 - 25,对于(134m)Cs(2.9小时)为0.6 - 9.5,对于(131)Cs(9.69天)为0.7 - 1.7,对于(134)Cs(2.06年)为0.7 - 1.1,对于(137)Cs(30.2年)为0.5 - 1.9,对于(135)Cs(2.3×10⁶年)为0.2 - 3.7。某些组织和铯同位素(特别是短寿命同位素)的导出剂量系数存在很大差异,这主要是由于铯在体内随时间分布的预测不同所致。例如,所提模型和当前ICRP关于铯职业摄入量的模型预测,静脉注射稳定铯后,肾脏峰值含量分别约为22%和约0.4%。基于所提的铯及其子体模型,半衰期≥10分钟的铯同位素中,唯一在剂量学上有显著意义的链成员是(137m)Ba,它占注入(137)Cs估计组织剂量的32 - 85%,以及(134)Cs,它占注入(134m)Cs估计组织剂量的4 - 53%。